v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
OPERATING EXPENSES    
Research and development $ 3,131 $ 1,313
Selling, general and administrative 4,767 3,163
Total operating expenses 7,898 4,476
Loss from operations (7,898) (4,476)
OTHER (EXPENSE) INCOME    
Change in fair value of derivative liability 28 0
Interest income 23 6
Interest expense (146) 0
Net other (expense) income (95) 6
Net loss from operations before discontinued operations (7,993) (4,470)
Loss from discontinued operations (885) (1,185)
Net loss $ (8,878) $ (5,655)
Net loss per share attributed to common stockholders - basic and diluted (in dollars per share) $ (7.84) $ (19.68)
Weighted-average number of shares - basic and diluted (in shares) 1,155,531 287,370